2225 - Analysis of Co-Resistance Among Escherichia coli Urine Isolates From Female Outpatients in the United States

Saturday, October 22, 2022

12:15 PM – 1:30 PM US ET

Location: Hall B + C

Presenting Author(s)

Keith S. Kaye, MD, MPH (he/him/his)

Chief, Division of Allergy, Immunology and Infectious Diseases
Rutgers - Robert Wood Johnson Medical School
New Brunswick, New Jersey, United States

Vikas Gupta, PharmD

Director, MMS Medical Affairs
Becton, Dickinson and Company (BD)
Franklin Lakes, New Jersey, United States
AM

Aruni Mulgirigama, MBBS

Global Medical Affairs Lead
GlaxoSmithKline plc.
Surrey, England, United Kingdom
Ashish V. Joshi, PhD

Senior Director
GlaxoSmithKline plc.
Collegeville, Pennsylvania, United States
NS

Nicole E. Scangarella-Oman, MS

Scientific Director
GlaxoSmithKline plc.
Collegeville, Pennsylvania, United States
KY

Kalvin Yu, MD, FIDSA

Vice President, Medical & Scientific Affairs
Becton, Dickinson and Company (BD)
Franklin Lakes, New Jersey, United States
JW

Janet Watts, PhD

Becton, Dickinson and Company (BD)
Franklin Lakes, New Jersey, United States
FM

Fanny S. Mitrani-Gold, MPH

Director, Epidemiology
GlaxoSmithKline plc.
Collegeville, Pennsylvania, United States